Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
ETABLISSEMENTS HENRI NOOTENS from Schaarbeek, company number BE0401991754, closed financial year 2025 with a result of € -467,739 after tax. For that financial year ETABLISSEMENTS HENRI NOOTENS recorded a gross margin of € 785,538 and equity of € 3.6 million. Compared with financial year 2024, the result moved from € -259,698 to € -467,739. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ 3.6 million
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -467,739
▼ 80 % more loss than in 2024
Profit after tax over the fiscal year.
€ 601,431
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3.5 million.
People and assets in 2025
12.8
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
▼ 7% vs 2024
€ 94,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,680
▼ 15% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 780,415
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 199,725
▼ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,329,661 | € 1,772,319 | € 1,142,874 | € 785,538 | ▼ 31% |
| Profit after taxes | € -27,450 | € 502,016 | € -259,698 | € -467,739 | ▼ € 208,041 |
| Equity | € 3,859,964 | € 4,361,980 | € 4,102,282 | € 3,634,543 | ▼ 11% |
| Total debts | € 1,446,280 | € 1,870,968 | € 1,674,560 | € 1,455,831 | ▼ 13% |
| Cash | € 946,165 | € 1,034,834 | € 715,173 | € 601,431 | ▼ 16% |
| Land & buildings | € 167,390 | € 186,279 | € 181,841 | € 178,270 | ▼ 2% |
| Retained profit | € 3,736,017 | € 4,238,033 | € 3,978,335 | € 3,510,596 | ▼ 12% |
| Balance sheet total | € 5,345,894 | € 6,261,748 | € 5,827,242 | € 5,128,894 | ▼ 12% |
| Employees (FTE) | 13.7 | 13 | 12.9 | 12.8 | ▼ 0.1 |
Key figures of ETABLISSEMENTS HENRI NOOTENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ETABLISSEMENTS HENRI NOOTENS?
What happened at ETABLISSEMENTS HENRI NOOTENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Laurence Nootens stepped down as director. NBB
- Pierre-Henri Nootens stepped down as director. NBB
- Valérie-Anne Docquier-Nootens stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 467,739. Source: NBB ↗
- Laurence Nootens became a director. NBB
- Pierre-Henri Nootens became a director. NBB
- Valérie-Anne Docquier-Nootens became a director. NBB
- New establishment in Schaarbeek. KBO
In short
From € 27,450 loss in 2022 to € 467,739 loss in 2025.
Paid € 5,978 in corporate taxes since 2022.
Best year ever: 2023, with € 502,016 profit.
On average € 61,400 of value added per employee in 2025.
A new publication or filing at ETABLISSEMENTS HENRI NOOTENS? We notify you, reason included.
Follow ETABLISSEMENTS HENRI NOOTENSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of HOSPIPLAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ETABLISSEMENTS HENRI NOOTENSThe shares are held by HOSPIPLAN (99.1%).
Directors
According to the 2025 annual accounts
Laurence Nootens
Director
since 2023 · until 2029
Pierre-Henri Nootens
Managing director
since 2023 · until 2029
Valérie-Anne Docquier-Nootens
Managing director
since 2023 · until 2029
Shareholders
99.1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Georges Rodenbachlaan 75
1030 Schaarbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0401.991.754
- VAT number
- BE 0401.991.754
- Registered office
- Georges Rodenbachlaan 75, 1030 Schaarbeek
- Names & denominations
- ETABLISSEMENTS HENRI NOOTENS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 1961
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten